Literature DB >> 25568067

Tumors: wounds that do not heal-redux.

Harold F Dvorak1.   

Abstract

Similarities between tumors and the inflammatory response associated with wound healing have been recognized for more than 150 years and continue to intrigue. Some years ago, based on our then recent discovery of vascular permeability factor (VPF)/VEGF, I suggested that tumors behaved as wounds that do not heal. More particularly, I proposed that tumors co-opted the wound-healing response to induce the stroma they required for maintenance and growth. Work over the past few decades has supported this hypothesis and has put it on a firmer molecular basis. In outline, VPF/VEGF initiates a sequence of events in both tumors and wounds that includes the following: increased vascular permeability; extravasation of plasma, fibrinogen and other plasma proteins; activation of the clotting system outside the vascular system; deposition of an extravascular fibrin gel that serves as a provisional stroma and a favorable matrix for cell migration; induction of angiogenesis and arterio-venogenesis; subsequent degradation of fibrin and its replacement by "granulation tissue" (highly vascular connective tissue); and, finally, vascular resorption and collagen synthesis, resulting in the formation of dense fibrous connective tissue (called "scar tissue" in wounds and "desmoplasia" in cancer). A similar sequence of events also takes place in a variety of important inflammatory diseases that involve cellular immunity. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25568067      PMCID: PMC4288010          DOI: 10.1158/2326-6066.CIR-14-0209

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  82 in total

Review 1.  Vascular endothelial growth factor: basic biology and clinical implications.

Authors:  N Ferrara; B Keyt
Journal:  EXS       Date:  1997

Review 2.  Wounds that will not heal: pervasive cellular reprogramming in cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Am J Pathol       Date:  2013-02-22       Impact factor: 4.307

3.  VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.

Authors:  J Li; L F Brown; M G Hibberd; J D Grossman; J P Morgan; M Simons
Journal:  Am J Physiol       Date:  1996-05

4.  The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation.

Authors:  A M Dvorak; S Kohn; E S Morgan; P Fox; J A Nagy; H F Dvorak
Journal:  J Leukoc Biol       Date:  1996-01       Impact factor: 4.962

Review 5.  Anti-VEGF/VEGFR therapy for cancer: reassessing the target.

Authors:  Basel Sitohy; Janice A Nagy; Harold F Dvorak
Journal:  Cancer Res       Date:  2012-04-15       Impact factor: 12.701

Review 6.  Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.

Authors:  P Allavena; A Mantovani
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

Review 7.  Vascular hyperpermeability, angiogenesis, and stroma generation.

Authors:  Janice A Nagy; Ann M Dvorak; Harold F Dvorak
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

8.  The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1.

Authors:  Liuliang Qin; Dezheng Zhao; Jianfeng Xu; Xianghui Ren; Ernest F Terwilliger; Sareh Parangi; Jack Lawler; Harold F Dvorak; Huiyan Zeng
Journal:  Blood       Date:  2013-01-11       Impact factor: 22.113

Review 9.  Inflammation and liver tumorigenesis.

Authors:  Beicheng Sun; Michael Karin
Journal:  Front Med       Date:  2013-05-17       Impact factor: 4.592

10.  Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin.

Authors:  D Feng; J A Nagy; J Hipp; H F Dvorak; A M Dvorak
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  157 in total

Review 1.  Glioblastoma niches: from the concept to the phenotypical reality.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Ilaria Bisogno; Cristina Casalone; Laura Annovazzi
Journal:  Neurol Sci       Date:  2018-05-08       Impact factor: 3.307

Review 2.  Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer.

Authors:  Constantinos P Zambirinis; George Miller
Journal:  Trends Mol Med       Date:  2017-04-08       Impact factor: 11.951

Review 3.  Brain Tumor Microenvironment and Host State: Implications for Immunotherapy.

Authors:  William Tomaszewski; Luis Sanchez-Perez; Thomas F Gajewski; John H Sampson
Journal:  Clin Cancer Res       Date:  2019-02-25       Impact factor: 12.531

Review 4.  Perspectives: MRI of angiogenesis.

Authors:  Michal Neeman
Journal:  J Magn Reson       Date:  2018-04-12       Impact factor: 2.229

5.  Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells.

Authors:  Michael Delacher; Malte Simon; Lieke Sanderink; Agnes Hotz-Wagenblatt; Marina Wuttke; Kathrin Schambeck; Lisa Schmidleithner; Sebastian Bittner; Asmita Pant; Uwe Ritter; Thomas Hehlgans; Dania Riegel; Verena Schneider; Florian Kai Groeber-Becker; Andreas Eigenberger; Claudia Gebhard; Nicholas Strieder; Alexander Fischer; Michael Rehli; Petra Hoffmann; Matthias Edinger; Till Strowig; Jochen Huehn; Christian Schmidl; Jens M Werner; Lukas Prantl; Benedikt Brors; Charles D Imbusch; Markus Feuerer
Journal:  Immunity       Date:  2021-03-30       Impact factor: 31.745

6.  Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.

Authors:  Basel Sitohy; Sunghee Chang; Tracey E Sciuto; Elizabeth Masse; Mei Shen; Peter M Kang; Shou-Ching Jaminet; Laura E Benjamin; Rupal S Bhatt; Ann M Dvorak; Janice A Nagy; Harold F Dvorak
Journal:  Am J Pathol       Date:  2017-07-21       Impact factor: 4.307

Review 7.  Cancer Metabolism Drives a Stromal Regenerative Response.

Authors:  Simon Schwörer; Santosha A Vardhana; Craig B Thompson
Journal:  Cell Metab       Date:  2019-02-14       Impact factor: 27.287

Review 8.  Platelet "first responders" in wound response, cancer, and metastasis.

Authors:  David G Menter; Scott Kopetz; Ernest Hawk; Anil K Sood; Jonathan M Loree; Paolo Gresele; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

Review 9.  FOXN1 Transcription Factor in Epithelial Growth and Wound Healing.

Authors:  Anna I Grabowska; Tomasz Wilanowski
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

10.  A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy.

Authors:  Matthew T Wolf; Sudipto Ganguly; Tony L Wang; Christopher W Anderson; Kaitlyn Sadtler; Radhika Narain; Christopher Cherry; Alexis J Parrillo; Benjamin V Park; Guannan Wang; Fan Pan; Saraswati Sukumar; Drew M Pardoll; Jennifer H Elisseeff
Journal:  Sci Transl Med       Date:  2019-01-30       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.